Adial Pharmaceuticals, Inc. Earnings Per Share (Basic)
Adial Pharmaceuticals, Inc. (ADIL) reported Earnings Per Share (Basic) of -$11.25 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Adial Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$11.25.
- Adial Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.48.
- Adial Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.08.
- Adial Pharmaceuticals, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$4.61.
- Adial Pharmaceuticals, Inc. earnings per share, basic for fiscal 2025 was -$11.93.
- Adial Pharmaceuticals, Inc. earnings per share, basic for fiscal 2024 was -$68.01.
- Adial Pharmaceuticals, Inc. earnings per share, basic for fiscal 2023 was -$3.60.
- Adial Pharmaceuticals, Inc. earnings per share, basic for fiscal 2022 was -$12.71.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$11.25 10-Q · filed 2026-08-14 | -$17.97 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | -$1.48 10-Q · filed 2026-05-08 | |||||||
| 2025-12-31 | -$11.93 10-K · filed 2026-03-05 | |||||||
| 2025-09-30 | -$0.08 10-Q · filed 2025-11-13 | -$0.45 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$4.61 10-Q · filed 2026-08-14 | -$0.18 10-Q · filed 2025-08-13 | -$12.19 10-Q · filed 2026-08-14 | -$0.49 10-Q · filed 2025-08-13 | ||||
| 2025-03-31 | -$8.52 10-Q · filed 2026-05-08 | -$0.34 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | -$68.01 10-K · filed 2026-03-05 | -$2.72 10-K · filed 2025-03-04 | ||||||
| 2024-09-30 | -$0.38 10-Q · filed 2025-11-13 | -$2.57 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | -$0.59 10-Q · filed 2025-08-13 | -$2.50 10-Q · filed 2025-08-13 | ||||||
| 2024-03-31 | -$2.19 10-Q · filed 2025-05-14 | |||||||
| 2023-12-31 | -$3.60 10-K · filed 2025-03-04 | |||||||
| 2023-09-30 | -$1.18 10-Q · filed 2024-11-13 | -$2.86 10-Q · filed 2024-11-13 | ||||||
| 2023-06-30 | $0.96 10-Q · filed 2024-08-13 | -$1.66 10-Q · filed 2024-08-13 | ||||||
| 2023-03-31 | -$0.11 10-Q · filed 2023-05-12 | |||||||
| 2022-12-31 | -$12.71 10-K · filed 2024-04-01 | -$0.51 10-K · filed 2023-03-30 | ||||||
| 2022-09-30 | -$3.02 10-Q · filed 2023-11-14 | -$0.12 10-Q · filed 2022-11-14 | -$9.94 10-Q · filed 2023-11-14 | -$0.40 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$3.96 10-Q/A · filed 2023-10-30 | -$0.16 10-Q · filed 2022-08-15 | -$7.24 10-Q/A · filed 2023-10-30 | -$0.29 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | -$0.13 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | -$1.04 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | -$0.22 10-Q · filed 2022-11-14 | -$0.76 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.25 10-Q · filed 2022-08-15 | -$0.55 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |